细菌性血流感染的疾病负担:流行病学及多重耐药病原体意义简报
本文综述细菌性血流感染的流行病学与疾病负担,检索以「bloodstream infection」和「bacteremia」结合「epidemiology」「burden」的同行评议文献,重点关注成人患者新信息及病原体对一线和二线抗菌药物耐药带来的额外负担。尽管基于人群的研究和大型多中心队列增多,区域层面和资源有限地区的监测与系统数据仍需加强,以优化预防与治疗策略。
要点
- 血流感染是病原体定义的异质性实体,便于研究与监测。
- 耐药病原体对一线和二线抗菌药物的耐药增加额外疾病负担。
- 区域层面和资源有限地区仍需更多监测与系统数据。
核心结论
- 尽管已有基于人群的研究和越来越多大型多中心队列,区域层面和资源有限地区的血流感染流行病学监测与系统数据仍需加强,以更好设计预防方法并优化治疗策略。
研究设计与样本
- 综述,检索同行评议文献,检索词为「bloodstream infection」和「bacteremia」结合「epidemiology」和「burden」,重点为成人患者新信息及病原体耐药额外负担。
主要发现
- 血流感染涵盖多种病原体和临床综合征,与非菌血症感染综合征有相当重叠,风险因素、治疗意义和结局多样。
临床怎么用
- 临床可利用病原体定义的血流感染实体进行研究与监测,并关注耐药病原体对一线和二线抗菌药物带来的额外负担。
局限性
- 区域层面和资源有限地区的监测与系统数据可能不足,需更多数据以优化预防与治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bloodstream infections comprise a wide variety of pathogens and clinical syndromes with considerable overlap with similar syndromes of non-bacteraemic infections and diverse risk factors, therapeutic implications and outcomes. Yet, this heterogeneous 'entity' has the advantage to be pathogen-defined compared with the broad and even more heterogeneous entity 'sepsis', and so has become helpful for clinicians and epidemiologists for research and surveillance purposes. The increasing availability of population-based and large multicentre well-defined cohort studies should allow us to assess with much confidence and in detail its burden, the significance of antimicrobial resistance, and areas of uncertainty regarding further epidemiological evolution and optimized treatment regimens. AIM: To review key aspects of bloodstream infection epidemiology and burden, and summarize recent news and questions concerning critical developments. SOURCES: Peer-reviewed articles based on the search terms 'bloodstream infection' and 'bacteremia' combined with the terms 'epidemiology' and 'burden'. The emphasis was on new information from studies in adult patients and on the added burden due to pathogen resistance to first- and second-line antimicrobial agents. CONTENT: Topics covered include recent developments in the epidemiology of bloodstream infection due to key pathogens and published information about the relevance of resistance for patient outcomes. IMPLICATIONS: Despite the availability of population-based studies and an increasing number of large well-defined multicentre cohort studies, more surveillance and systematic data on bloodstream infection epidemiology at regional level and in resource-limited settings may be needed to better design new methods for prevention and define the need for and further develop optimized therapeutic strategies.
引用
- Kern WV, Rieg S. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2019. PMID: 31712069. doi:10.1016/j.cmi.2019.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。